Tele: 561.316.3330

Breaking Medical Device Industry News

Saturday, October 23, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeMEDTRONIC plcMedtronic Announces FDA Approval and U.S. Launch of Next Generation Pacemakers
HomeMEDTRONIC plcMedtronic Announces FDA Approval and U.S. Launch of Next Generation Pacemakers

Medtronic Announces FDA Approval and U.S. Launch of Next Generation Pacemakers

Azure(TM) with BlueSync(TM) Technology Improves Device Longevity and Provides Automatic, Wireless Remote Patient Monitoring

Medtronic reports the Azure pacemakers to feature Medtronic-exclusive BlueSync technology, which enables automatic, secure wireless remote monitoring via the Medtronic CareLink(TM)Network, providing timely alerts of clinically relevant patient events that can be reviewed by a clinician at any time. Security controls implemented and validated on BlueSync enabled devices to include access restrictions to protect the integrity of device functionality and end-to-end encryption to protect patient data.

The Azure XT pacemaker features the Medtronic Reactive ATP(TM) (atrial-based antitachycardia pacing) algorithm, which was shown in the MINERVA Trial and real-world studies to slow the progression of atrial fibrillation (AF) in patients with implanted cardiac devices.2 Common among patients with cardiac devices, AF impairs quality of life and increases the risk of hospitalization, stroke and death.3

John Liddicoat, M.D., senior vice president, Medtronic, and president of the Cardiac Rhythm and Heart Failure division, “With the approval of Azure, clinicians managing patients with bradycardia now have pacemakers with improved longevity, and better ability to detect and reduce atrial fibrillation.”  He adds,  “BlueSync technology with Azure also enables secure and automatic wireless data transmission to clinicians. Remote monitoring with automatic data transmissions can result in earlier clinical decisions and improved patient monitoring compliance.”

In tandem with the approval of these new pacemakers, the Medtronic Percepta(TM) portfolio of quadripolar, MR-conditional cardiac resynchronization therapy pacemakers (CRT-Ps) also now includes BlueSync technology for secure, wireless remote monitoring via the Medtronic CareLink Network.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

By using this website you agree to accept Medical Device News Magazine Privacy Policy